{"id":"F2014L01277","name":"Therapeutic Goods (Listing) Notice 2014 (No. 5)","slug":"therapeutic-goods-listing-notice-2014-no-5","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":92291,"registerId":"commonwealth-F2014L01277-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2014 (No. 5)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2014 (No. 5)\n\nI, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n-   preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘glutathione’ as a therapeutically active ingredient, subject to the following conditions:\n\n    the preparations are for oral use only; and\n\n    the preparations are for use in adults only; and\n\n    the preparations are not indicated for use in pregnant or lactating women.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 3rd day of September 2014\n\n(Signed by)\n\nJohn Skerritt\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1427},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The instrument maintains its original narrow scope of temporarily listing a specific active ingredient with defined restrictions until permanent regulatory amendments take effect."},"complexity_factors":["Very short instrument (under 300 words)","Specifies only one active ingredient (glutathione)","Simple three-part condition structure with no nesting","No complex cross-references beyond basic statutory authority","Sunset clause (automatic expiry) tied to a clear future event"],"plain_english_summary":"This notice temporarily permits glutathione-containing dietary supplements to be sold in Australia as lower-risk \"listed\" therapeutic goods, allowing import and marketing while permanent regulations are updated. Products must be oral, for adults only, and must not be indicated for use in pregnancy or breastfeeding."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2014-no-5","history":"/api/acts/therapeutic-goods-listing-notice-2014-no-5/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2014-no-5/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2014-no-5/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2014-no-5/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2014-no-5/documents"}}